Clinical Trials Browser

Phase EARLY_PHASE1 × Ovarian Neoplasms × pembrolizumab × Clear all

NCT03514121 2024-11-22

FPA150-001

Phase EARLY_PHASE1 Terminated

95 enrolled 36 charts

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms